Literature DB >> 3895627

Drug-induced tolerance to allografts in mice. VI. Tolerance induction in H-2-haplotype-identical strain combinations in mice.

H Mayumi, K Himeno, T Shin, K Nomoto.   

Abstract

When C3H/HeN (C3H) mice were primed with viable AKR/J (AKR) spleen cells and treated with cyclophosphamide (CP) two days later, a profound tolerance to AKR skin grafts was induced. This tolerance was induced also in other combinations disparate only at minor histocompatibility (H) antigens (AKR-C3H and BALB/c[BALB]-DBA/2[DBA]). In C3H mice made tolerant to AKR, delayed foot-pad reaction (DFR), cytotoxic lymphocytes (CTL), and cytotoxic antibodies (CTAb) against AKR spleen cells were abrogated completely. Tolerance to AKR mice was also observed in C3H mice primed with viable AKR and C57BL/6 (B6) spleen cells and treated with CP, but tolerance to B6 was not induced because a cell population responsible for DFR and CTL against B6 H-2 antigens remained after tolerance induction. These results suggest that there is a lymphocyte population responsible for DFR and CTL against antigens allogeneic at both major and minor H that is less proliferative than the population responsible for DFR and CTL against minor H antigens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3895627     DOI: 10.1097/00007890-198508000-00016

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

1.  Importance of intrathymic mixed chimerism for the maintenance of skin allograft tolerance across fully allogeneic antigens in mice.

Authors:  M Eto; Y Y Kong; J Uozumi; S Naito; K Nomoto
Journal:  Immunology       Date:  1999-03       Impact factor: 7.397

2.  A surgical technique for experimental free skin grafting in mice.

Authors:  H Mayumi; K Nomoto; R A Good
Journal:  Jpn J Surg       Date:  1988-09

Review 3.  HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide.

Authors:  E J Fuchs
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

4.  Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamide.

Authors:  Ashley T Munchel; Yvette L Kasamon; Ephraim J Fuchs
Journal:  Best Pract Res Clin Haematol       Date:  2011-07-13       Impact factor: 3.020

5.  Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.

Authors:  M Eto; H Mayumi; Y Tomita; Y Yoshikai; K Nomoto
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

6.  Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming.

Authors:  T Maeda; M Eto; Y Nishimura; K Nomoto; Y Y Kong; K Nomoto
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

Review 7.  Transplantation tolerance: from theory to clinic.

Authors:  Ephraim J Fuchs
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

Review 8.  Transplantation of hematopoietic stem cells for induction of unresponsiveness to organ allografts.

Authors:  Tatyana Prigozhina; Shimon Slavin
Journal:  Springer Semin Immunopathol       Date:  2004-09-11

9.  Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.

Authors:  H Mayumi; R A Good
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide.

Authors:  Ashley Munchel; Chimen Kesserwan; Heather J Symons; Leo Luznik; Yvette L Kasamon; Richard J Jones; Ephraim J Fuchs
Journal:  Pediatr Rep       Date:  2011-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.